Clinical Trials in New York State

Showing 13221-13240 of 17,167 trials

A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma

NCT01122875

This is a multicenter, open-label, dose-escalation study of MFGR1877S in patients with relapsed or refractory t(4;14)-positive multiple myeloma.

Multiple Myeloma

Genentech, Inc.14 participantsStarted Nov 2010

Scottsdale, Arizona, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +9 more locations

COMPLETEDPhase 3100 miles

A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients

NCT00048152

This study will compare kidney function in kidney transplant patients following treatment with various combinations of Zenapax, CellCept, corticosteroids, and Neoral (Cyclosporine). The anticipated time on study treatment is 6-12 months, and the target sample size is 500+ individuals.

Kidney Transplantation

Hoffmann-La Roche539 participantsStarted Dec 2000

Birmingham, Alabama, United States • San Francisco, California, United States • Gainesville, Florida, United States +33 more locations

A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma

A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients

Find Trials by Condition in New York State

A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age

A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)

A Study of MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Head And Neck

A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER)

A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma

A Study of RO5045337 [RG7112] in Patients With Advanced Solid Tumors

A Study of Mircera for the Treatment of Anemia in Dialysis Patients

A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.

Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder

A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.

A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.

A Study of GDC-0941 in Participants With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable

A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.

VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients

GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors

A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.